These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10263965)

  • 1. Theoretical considerations on the cost of illness.
    Goddeeris JH
    J Health Econ; 1983 Aug; 2(2):149-59. PubMed ID: 10263965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A note on the relationship between ex ante and expected willingness to pay for health care.
    Johannesson M
    Soc Sci Med; 1996 Feb; 42(3):305-11. PubMed ID: 8658226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic cost of illness in the Federal Republic of Germany in the year 1980.
    Henke KD; Behrens CS
    Health Policy; 1986; 6(2):119-43. PubMed ID: 10311581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of disease and illness in the United States in the year 2000.
    Public Health Rep; 1978; 93(5):493-588. PubMed ID: 100825
    [No Abstract]   [Full Text] [Related]  

  • 5. The state of the art of cost-of-illness estimates.
    Hodgson TA
    Adv Health Econ Health Serv Res; 1983; 4():129-64. PubMed ID: 10265653
    [No Abstract]   [Full Text] [Related]  

  • 6. Problems in measuring the cost of illness.
    Cohodes DR
    Eval Health Prof; 1982 Dec; 5(4):381-92. PubMed ID: 10257865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
    Neumann PJ; Johannesson M
    Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness-to-pay for community-based insurance in Burkina Faso.
    Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
    Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumer information surplus and adverse selection in competitive health insurance markets: an empirical study.
    van de Ven WP; van Vliet RC
    J Health Econ; 1995 Jun; 14(2):149-69. PubMed ID: 10154655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concept of cost in the economic evaluation of health care. A theoretical inquiry.
    Johannesson M
    Int J Technol Assess Health Care; 1994; 10(4):675-82. PubMed ID: 7843887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cost-benefit analysis of tele-homecare for community-dwelling elderly in Japan: Non-Government versus Government Supported Funding Models.
    Akiyama M; Abraham C
    Int J Med Inform; 2017 Aug; 104():1-9. PubMed ID: 28599810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and distributional impacts of employer health insurance mandates and Medicaid expansion.
    Thorpe KE
    Inquiry; 1989; 26(3):335-44. PubMed ID: 2529211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts.
    Finkelstein A; Hendren N; Shepard M
    Am Econ Rev; 2019 Apr; 109(4):1530-67. PubMed ID: 30990593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding health insurance coverage: who will pay?
    Cantor JC
    J Health Polit Policy Law; 1990; 15(4):755-78. PubMed ID: 2081886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of human life: a review of the models.
    Linnerooth J
    Econ Inq; 1979 Jan; 17(1):52-74. PubMed ID: 10308794
    [No Abstract]   [Full Text] [Related]  

  • 16. The uninsured and the financing of uncompensated care: scope, costs, and policy options.
    Mulstein S
    Inquiry; 1984; 21(3):214-29. PubMed ID: 6237055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic cost of illness: decision-making applications and practical considerations.
    Tolpin HG; Bentkover JD
    Adv Health Econ Health Serv Res; 1983; 4():165-98. PubMed ID: 10265654
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-benefit analysis involving addictive goods: contingent valuation to estimate willingness-to-pay for smoking cessation.
    Weimer DL; Vining AR; Thomas RK
    Health Econ; 2009 Feb; 18(2):181-202. PubMed ID: 18566968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.